Impact Factor 5.810 | CiteScore 6.2
More on impact ›
Pharmacoepidemiology is the study of the utilization and effects of medications in large human populations, bridging clinical pharmacology and epidemiology. We welcome all submissions that provide insight into pharmacoepidemiological or real-world evidence drug research.
Read MorePharmacoepidemiology is the study of the utilization and effects of medications in large human populations, and it is a bridge science spanning both clinical pharmacology and epidemiology. It estimates the risks and benefits of medication use on various important physical and mental health outcomes.
Pharmacoepidemiology research is essential to identify rare but severe adverse outcomes once a drug is marketed; study risks and benefits in populations excluded from randomized clinical trials; and is increasingly being used for public health and clinical decisions.
The Pharmacoepidemiology section of Frontiers in Pharmacology publishes high-quality epidemiological, clinical, and translational original research across the fields of clinical pharmacology, epidemiology, and real-world evidence.
Areas covered by this section include, but are not limited to:
All studies must contribute insights into pharmacoepidemiological or real-world evidence drug research. Reports dealing with basic pharmacology, target identification, medicinal chemistry, biopharmacy or epidemiology unrelated to drugs do not fall within the scope of this section and might be submitted to other sections in Frontiers in Pharmacology or to other Frontiers journals.
Indexed in: Chemical Abstracts Service (CAS), CrossRef, DOAJ, Google Scholar, PubMed, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE)
Pharmacoepidemiology welcomes submissions of the following article types: Brief Research Report, Clinical Trial, Correction, Data Report, Editorial, Erratum, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Pharmacoepidemiology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41 (0)21 510 17 00
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41 (0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact pharmacology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact pharmacology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org